Karen Prange serves as Executive at BOSTON SCIENTIFIC CORP, where they oversee executive responsibilities. Since joining the company, Karen Prange has executed 56 insider transactions totaling $1.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 2, 2014 involved exercising options for 25,862 shares valued at $0.
Karen Prange currently holds 33,948 shares of BOSTON SCIENTIFIC CORP (BSX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Prange has been a net seller of BSX stock. They have purchased $100.0K and sold $1.0M worth of shares.
Karen Prange's most recent insider trade was on Jul 2, 2014, when they sold 25,862 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $13.13 |
| Discretionary |
| Feb 28, 2014 | BSX | $0 | Option Exercise | 3,721 | $N/A | Discretionary |
| Feb 28, 2014 | BSX | $18.5K | Payment | 1,411 | $13.10 | Discretionary |
| Jul 2, 2013 | BSX | $77.3K | Payment | 8,432 | $9.17 | Discretionary |
| Jul 2, 2013 | BSX | $0 | Option Exercise | 25,862 | $N/A | Discretionary |